| 2024-01-08 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP,General Counsel, Secretary | 590 0.0004% | $29.96 | $17,676 | -40.14% | |
| 2023-10-06 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP,General Counsel, Secretary | 16,369 0.0101% | $21.96 | $359,463 | +2.77% | |
| 2023-05-01 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP,General Counsel, Secretary | 917 0.0006% | $21.18 | $19,422 | +10.67% | |
| 2023-04-06 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP,General Counsel, Secretary | 1,456 0.0009% | $18.16 | $26,441 | +31.17% | |
| 2023-02-24 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP,General Counsel, Secretary | 803 0.0005% | $18.78 | $15,080 | +26.85% | |
| 2023-01-09 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP,General Counsel, Secretary | 589 0.0004% | $17.13 | $10,090 | +34.98% | |
| 2022-04-29 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP,General Counsel, Secretary | 894 0.0005% | $18.18 | $16,255 | -8.95% | |
| 2022-02-23 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP & General Counsel | 782 0.0005% | $23.80 | $18,612 | -32% | |
| 2022-01-06 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP & General Counsel | 574 0.0004% | $23.05 | $13,231 | -28.22% | |
| 2021-04-30 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP & General Counsel | 1,054 0.0006% | $20.33 | $21,428 | +6.52% | |
| 2021-02-04 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP & General Counsel | 2,107 0.0013% | $50.61 | $106,635 | -57.96% | |
| 2021-01-06 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP & General Counsel | 678 0.0004% | $53.34 | $36,165 | -59.88% | |
| 2020-10-27 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP & General Counsel | 8,750 0.0053% | $45.10 | $394,636 | -47.63% | |
| 2020-04-30 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP & General Counsel | 1,072 0.0007% | $49.22 | $52,764 | -2.75% | |
| 2019-12-11 | Sale | ACADIA Pharmaceuticals Inc. ACAD | EVP & General Counsel | 17,500 0.0113% | $45.06 | $788,576 | -2.13% |